This research compound formulation contains CJC-1295, a GHRH analog, and Ipamorelin, a GHRP receptor agonist. This combination is intended for in vitro studies investigating the interactions between these two distinct classes of secretagogues on cellular signaling pathways in controlled laboratory models.
Key Specifications:
- ICN: 1-14-641 / 1-14-642
- Alias: Mod GRF 1-29 / Ipamorelin
- Strength: 5mg/5mg | 10mg/10mg
- Purity: >99%
Storage Instructions:
Store in a cool, dry place at -20°C. Protect from light. Reconstituted solutions should be stored under sterile conditions at 2-8°C.
Disclaimer:
For research use only. Not for human or veterinary use. Not for consumption or therapeutic application.
